Unfortunately, our biomedical system is designed for the development and testing of one drug at at time. Combinations of drugs dramatically increase ...
News
- No cure for Alzheimer's disease in my lifetime
- Analysts See $-0.22 EPS for Celcuity Inc. (CELC)
... 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive ... 2018 as well as Bizjournals.com's news article titled: “Biotech startup Celcuity raises $23M in IPO – Minneapolis ...
- SkinTE Clinical Data to be Presented, PolarityTE to Host Booth and SkinTE Event at Symposium on ...
SALT LAKE CITY, April 24, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative ... Wound Healing Society meeting in San Antonio, TX from May 7 – 11, 2019.
- Analysts See $-0.22 EPS for Celcuity Inc. (CELC)
... Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with ... Bizjournals.com and their article: “Biotech startup Celcuity raises $23M in IPO – Minneapolis / St. Paul Business ...
- How Cyril Moukarzel Is Using DNA to Create the Future of Personalized Medicine
This interview is with Cyril Moukarzel, co-founder and CEO of LifeDNA, a biotechnology company focused on improving lives using genetics.